Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Medpace Holdings, Inc.

Revenue, Net

Revenue, Net %Chg

Revenue, Net Common Size

Direct Service Costs, Excluding Depreciation and Amortization

Direct Service Costs, Excluding Depreciation and Amortization %Chg

Direct Service Costs, Excluding Depreciation and Amortization Common Size

Reimbursed Out-of-Pocket Expenses

Reimbursed Out-of-Pocket Expenses %Chg

Reimbursed Out-of-Pocket Expenses Common Size

Total Direct Costs

Total Direct Costs %Chg

Total Direct Costs Common Size

Selling, General and Administrative

Selling, General and Administrative %Chg

Selling, General and Administrative Common Size

Impairment of Goodwill

Impairment of Goodwill %Chg

Impairment of Goodwill Common Size

Depreciation

Depreciation %Chg

Depreciation Common Size

Amortization

Amortization %Chg

Amortization Common Size

Total Operating Expenses

Total Operating Expenses %Chg

Total Operating Expenses Common Size

Income from Operations

Income from Operations %Chg

Income from Operations Common Size

Loss on Extinguishment of Debt

Loss on Extinguishment of Debt %Chg

Loss on Extinguishment of Debt Common Size

Miscellaneous (Expense) Income, Net

Miscellaneous (Expense) Income, Net %Chg

Miscellaneous (Expense) Income, Net Common Size

Interest Expense, Net

Interest Expense, Net %Chg

Interest Expense, Net Common Size

Interest Income (Expense), Net

Interest Income (Expense), Net %Chg

Interest Income (Expense), Net Common Size

Total Other Income, Net

Total Other Income, Net %Chg

Total Other Income, Net Common Size

Income Before Income Taxes

Income Before Income Taxes %Chg

Income Before Income Taxes Common Size

Income Tax Provision

Income Tax Provision %Chg

Income Tax Provision Common Size

Net Income

Net Income %Chg

Net Income Common Size

Basic

Basic %Chg

Basic Common Size

Diluted

Diluted %Chg

Diluted Common Size

Total Revenues

Total Revenues %Chg

Total Revenues Common Size

Cost of Sales

Cost of Sales %Chg

Cost of Sales Common Size

Gross Profit

Gross Profit %Chg

Gross Profit Common Size

Gross Profit Margin

Gross Profit Margin %Chg

Gross Profit Margin Common Size

Selling, General & Administrative Expenses

Selling, General & Administrative Expenses %Chg

Selling, General & Administrative Expenses Common Size

Depreciation & Amortization Expenses

Depreciation & Amortization Expenses %Chg

Depreciation & Amortization Expenses Common Size

Other Operating Expenses

Other Operating Expenses %Chg

Other Operating Expenses Common Size

Operating Profit

Operating Profit %Chg

Operating Profit Common Size

Operating Margin

Operating Margin %Chg

Operating Margin Common Size

Interest Expense

Interest Expense %Chg

Interest Expense Common Size

Non-Operating Income

Non-Operating Income %Chg

Non-Operating Income Common Size

Total Non-Operating Income

Total Non-Operating Income %Chg

Total Non-Operating Income Common Size

Income Before Provision for Income Taxes

Income Before Provision for Income Taxes %Chg

Income Before Provision for Income Taxes Common Size

Provision for Income Taxes

Provision for Income Taxes %Chg

Provision for Income Taxes Common Size

Consolidated Net Income

Consolidated Net Income %Chg

Consolidated Net Income Common Size

Net Income Attributable to Common Shareholders

Net Income Attributable to Common Shareholders %Chg

Net Income Attributable to Common Shareholders Common Size

Basic EPS

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Adjusted Net Income

Net Revenue

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Income Statement	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Total Revenues	2,358.4	2,231.8	2,156.6	2,109.1	2,070.9	2,030
Total Revenues %Chg	13.9%	9.9%	9.9%	11.8%	16.2%	21.4%
Revenue, Net
Cost of Sales	1,624.8	1,526.1	1,477.1	1,452.7	1,456.1	1,451.1
Direct Service Costs, Excluding Depreciation and Amortization
Reimbursed Out-of-Pocket Expenses
Gross Profit	733.6	705.7	679.5	656.3	614.8	579
Gross Profit Margin	31.1%	31.6%	31.5%	31.1%	29.7%	28.5%
Selling, General & Administrative Expenses	198.1	199.2	194	180.2	177.3	169.5
Selling, General and Administrative
Depreciation & Amortization Expenses	28.5	29	29.2	29.3	28.7	28.1
Depreciation
Amortization
Other Operating Expenses	—	—	—	—	—	—
Impairment of Goodwill
Operating Profit	507	477.5	456.3	446.9	408.8	381.4
Income from Operations
Operating Margin	21.5%	21.4%	21.2%	21.2%	19.7%	18.8%
Interest Expense	—	—	—	25	—	—
Interest Expense, Net
Interest Income (Expense), Net
Non-Operating Income	—	—	—	29.1	—	4.4
Loss on Extinguishment of Debt
Miscellaneous (Expense) Income, Net
Interest Income (Expense), Net
Total Non-Operating Income	—	—	—	54	—	4.4
Income Before Provision for Income Taxes	519.4	495.4	481.3	475.9	432.7	397.2
Income Before Income Taxes
Provision for Income Taxes	86.4	77.1	64.9	71.5	67.1	57.4
Income Tax Provision
Consolidated Net Income	433	418.3	416.4	404.4	365.7	339.8
Net Income
Net Income Attributable to Common Shareholders	433	418.3	416.4	404.4	365.7	339.8
Net Income
Basic EPS	14.7	13.8	13.5	13.1	11.8	11
Diluted EPS	14.3	13.5	13.1	12.6	11.4	10.6
Basic Weighted Average Shares Outstanding	29.5	30.2	30.8	31	30.9	30.8
Total Shares Outstanding	28.2	28.1	29.8	30.6	31.1	31
Diluted Weighted Average Shares Outstanding	30.3	31.1	31.8	32	32	31.9
EBITDA	535.5	506.5	485.5	476.1	437.5	409.5
Effective Tax Rate	16.6%	15.6%	13.5%	15%	15.5%	14.4%